Latest Twitter News | Page 3

Big tech is Ignoring Human Cost Behind Rise of ChatGPT
Eurovision 2023: What Australian viewers can expect
Feed me: 4 ways to take control of social media algorithms and get the content you actually want
Ultomiris approved in the EU for adults with neuromyelitis optica spectrum disorder (NMOSD)
Farxiga extended in the US to reduce risk of cardiovascular death and hospitalisation for heart failure to a broader range of patients
Koselugo approved in China for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
Amcor Recognized as Top Leader in Sustainable Innovations
NEURO-TTRansform Phase III results presented at AAN showed eplontersen demonstrated consistent and sustained improvement in all measures of disease and quality of…
Twitter users feeling hot, hot, hot during heat waves according to study
Imfinzi-based treatment before and after surgery reduced the risk of disease recurrence, progression events or death by 32% in resectable non-small cell…
ECCMID data reinforces AstraZeneca’s commitment to transform protection for the most vulnerable by advancing science in vaccines and immune therapies
Record fine for wagering company Betr over gambling advertisements
Man charged with alleged online procurement of child – Strike Force Trawler
Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi
Teens who trust online information find it less stressful
Calls to regulate AI are growing louder. But how exactly do you regulate a technology like this?
Thumbs down: Why using too many emojis to substitute words can harm your chances online
What are microaggressions? And how can they affect our health?
Ultomiris recommended for approval in the EU by CHMP for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
Jamarra Ugle-Hagan and football’s cycle of racist abuse
License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed
Bank impersonation scams robbing Australians of their life savings
Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) through 66 weeks
Calquence granted first regulatory approval in China for adults with previously treated mantle cell lymphoma
Nurses converge to future proof workforce
Tagrisso demonstrated strong overall survival benefit in the ADAURA Phase III trial for adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
Imfinzi significantly improved event-free survival in AEGEAN Phase III trial for patients with resectable non-small cell lung cancer
Woke brands must match promises with practice: new book
International Women’s Day prompts calls for tech equity
Public inquiry into corruption allegations concerning Inner West Council, Transport for NSW and others
Kids’ online safety under the spotlight as digital industry called to account
Man charged with online child sex offence – Strike Force Trawler
Digital industry held to account for kids’ safety online
Twitter, TikTok and Google forced to answer tough questions about online child abuse
U.S. labor strikes up 52% in 2022 as worker activism rises
Watch and Act Message Owen
Disability and dignity – 4 things to think about if you want to ‘help’
Using chatter on the grapevine to ace cybersecurity report card
Using chatter on grapevine to ace cybersecurity report card
Emergency Warning Message – PORT LINCOLN, STAMFORD DRIVE
Australian nurse to be carved into history
NAB takes action to help stop spoofing scams
Have a heart-to-heart with loved ones to help stop scams this Valentine’s Day
Government urges people to prepare for Cyclone Gabrielle
Prosocial CEOs increase company value, stakeholder satisfaction
Free speech vs. harmful misinformation
UNOSAT Emergency Mapping Service Activated over Syria and Türkiye Following Major Earthquakes
Committee on the Rights of the Child Holds Fourteenth Informal Meeting with States